SFPG
IBB icon

Stonebridge Financial Planning Group’s iShares Biotechnology ETF IBB Stock Holding History

Stonebridge Financial Planning Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,205
Closed -$421K – 125
2022
Q4 		$421K Buy
3,205
+162
+5% +$20.9K 0.28% 90
2022
Q3 		$356K Buy
+3,043
New +$378K 0.25% 90

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Stonebridge Financial Planning Group's IBB Position: Q1 2023 in Review

Stonebridge Financial Planning Group sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 3,205 shares — an estimated $421K sold.

Stonebridge Financial Planning Group first reported a position in IBB in Q3 2022 and held it in 2 quarters. The position peaked at $421K in Q4 2022. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

  • Stonebridge Financial Planning Group reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
  • Stonebridge Financial Planning Group sold 3,205 iShares Biotechnology ETF shares in Q1 2023, an estimated $421K.
  • Stonebridge Financial Planning Group first reported a position in iShares Biotechnology ETF in Q3 2022 and held it in 2 quarters.
  • Stonebridge Financial Planning Group's iShares Biotechnology ETF position peaked at $421K in Q4 2022.
  • 866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on Stonebridge Financial Planning Group's 13F filing for Q1 2023, filed 4 May 2023.